Here's Why Presbia Is Worth $14/Share, Despite Plummeting Monday
May 23, 2016 at 12:21 PM EDT
Rodman & Renshaw maintains a Buy rating on Presbia PLC (NASDAQ: LENS) after an interim data from the company showed that its corneal ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.